NCT04911907 - Clinical Study of Utidelone Injection in Patients With Advanced or Metastatic Solid Tumors | Biotech Hunter

Enrollment

120

Participants

Timeline

Start Date

January 22, 2021

Primary Completion Date

March 15, 2024

Study Completion Date

December 30, 2024

Conditions

Solid Tumor

Interventions

DRUG

utidelone injection

Utidelone monotherapy 35 mg/m2/day IV transfusing over 90 min. on day 1-day 5 of each 21 day cycle

Trial Locations (3)

RECRUITING

Luhe Hospital, Capital Medical University, Beijing

RECRUITING

Obstetrics and Gynecology Hospital, Capital Medical University, Beijing

RECRUITING

Shanghai East Hospital of Tongji University, Shanghai